<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="EN" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Pharmacol</journal-id><journal-id journal-id-type="pmc-domain-id">282</journal-id><journal-id journal-id-type="pmc-domain">brjpharm</journal-id><journal-title-group><journal-title>British Journal of Pharmacology</journal-title></journal-title-group><issn pub-type="ppub">0007-1188</issn><issn pub-type="epub">1476-5381</issn><publisher><publisher-name>Wiley</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC1572517</article-id><article-id pub-id-type="pmcid-ver">PMC1572517.1</article-id><article-id pub-id-type="pmcaid">1572517</article-id><article-id pub-id-type="pmcaiid">1572517</article-id><article-id pub-id-type="pmid">11139459</article-id><article-id pub-id-type="doi">10.1038/sj.bjp.0703759</article-id><article-id pub-id-type="pii">0703759</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Papers</subject></subj-group></article-categories><title-group><article-title>Modelling of the blood-brain barrier transport of morphine-3-glucuronide studied using microdialysis in the rat: involvement of probenecid-sensitive transport</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Xie</surname><given-names initials="R">Rujia</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bouw</surname><given-names initials="MR">M Ren&#233;</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hammarlund-Udenaes</surname><given-names initials="M">Margareta</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="caf1">*</xref></contrib></contrib-group><aff id="aff1"><label>1</label><sup>1</sup>Department of Pharmacy, Division of Biopharmaceutics and Pharmacokinetics, Uppsala University, Box 580, S-751 23, Uppsala, Sweden</aff><author-notes><corresp id="caf1"><label>*</label>Author for correspondence: <email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mailto:Margareta.Hammarlund-Udenaes@biof.uu.se">Margareta.Hammarlund-Udenaes@biof.uu.se</email></corresp></author-notes><pub-date pub-type="ppub"><month>12</month><year>2000</year></pub-date><volume>131</volume><issue>8</issue><issue-id pub-id-type="pmc-issue-id">134851</issue-id><fpage>1784</fpage><lpage>1792</lpage><history><date date-type="received"><day>12</day><month>06</month><year>2000</year></date><date date-type="rev-recd"><day>25</day><month>09</month><year>2000</year></date><date date-type="accepted"><day>06</day><month>10</month><year>2000</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>12</month><year>2001</year></date></event><event event-type="pmc-live"><date><day>10</day><month>01</month><year>2008</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2010-12-23 17:21:12.403"><day>23</day><month>12</month><year>2010</year></date></event></pub-history><permissions><copyright-statement>Copyright 2000, Nature Publishing Group</copyright-statement><copyright-year>2000</copyright-year><copyright-holder>Nature Publishing Group</copyright-holder></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="131-0703759a.pdf"/><abstract><p><list list-type="order"><list-item><p>The objective of this study was to investigate the impact of probenecid on the blood-brain barrier (BBB) transport of morphine-3-glucuronide (M3G).</p></list-item><list-item><p>Two groups of rats received an exponential infusion of M3G over 4&#8201;h to reach a target plasma concentration of 65&#8201;&#956;<sc>M</sc> on two consecutive days. Probenecid was co-administered in the treatment group on day 2. Microdialysis was used to estimate unbound M3G concentrations in brain extracellular fluid (ECF) and blood. <italic>In vivo</italic> recovery of M3G was calculated with retrodialysis by drug, preceding the drug administration. The BBB transport was modelled using NONMEM.</p></list-item><list-item><p>In the probenecid group, the ratio of the steady-state concentration of unbound M3G in brain ECF to that in blood was 0.08&#177;0.02 in the absence and 0.16&#177;0.05 in the presence of probenecid (<italic>P</italic>=0.001). In the control group, no significant difference was found in this ratio between the 2 days (0.11&#177;0.05 and 0.10&#177;0.02, respectively). The process that appears to be mainly influenced by probenecid is influx clearance into the brain (0.11&#8201;&#956;l&#8201;min<sup>&#8722;1</sup>&#8201;g-brain<sup>&#8722;1</sup> <italic>vs</italic> 0.17&#8201;&#956;l&#8201;min<sup>&#8722;1</sup>&#8201;g-brain<sup>&#8722;1</sup>, in the absence <italic>vs</italic> presence of probenecid, <italic>P</italic>&lt;0.001). The efflux clearance was 1.15&#8201;&#956;l&#8201;min<sup>&#8722;1</sup>&#8201;g-brain<sup>&#8722;1</sup>. The half-life of M3G was 81&#177;25&#8201;min in brain ECF <italic>vs</italic> 22&#177;2&#8201;min in blood (<italic>P</italic>&lt;0.0001). Blood pharmacokinetics was not influenced by probenecid.</p></list-item><list-item><p>In conclusion, a probenecid-sensitive transport system is involved in the transport of M3G across the BBB.</p></list-item></list></p></abstract><kwd-group><kwd>Microdialysis</kwd><kwd>blood-brain barrier</kwd><kwd>morphine-3-glucuronide</kwd><kwd>multidrug resistance protein</kwd><kwd>drug transport</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>